Evidence map›Paper›PMID 30796224›Full record

ArticleNature communications2019

Copper-catalyzed oxidative benzylic C-H cyclization via iminyl radical from intermolecular anion-radical redox relay.

Xiang-Huan Shan, Hong-Xing Zheng, Bo Yang, Lin Tie, Jia-Le Fu, Jian-Ping Qu, Yan-Biao Kang

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiang-Huan ShanDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China.
Hong-Xing ZhengDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China.
Bo YangDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China.
Lin TieDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China.
Jia-Le FuDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China.
Jian-Ping QuInstitute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials, Nanjing Tech University, 211816, Nanjing, China. ias_jpqu@njtech.edu.cn.
Yan-Biao KangDepartment of Chemistry, University of Science and Technology of China, 230026, Hefei, Anhui, China. ybkang@ustc.edu.cn.ORCID http://orcid.org/0000-0002-7537-4627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Base-promoted C-H cleavage without transition metals opens a practical alternative for the one based on noble metals or radical initiators. The resulting carbanion can pass through radical addition to unsaturated bonds like C-N or C-C triple bonds, in which stoichiometric oxidants are needed. When in situ C-H cleavage meets catalytic carbanion-radical relay, it turns to be challenging but has not been accomplished yet. Here we report the combination of base-promoted benzylic C-H cleavage and copper-catalyzed carbanion-radical redox relay. Catalytic amount of naturally abundant and inexpensive copper salt, such as copper(II) sulfate, is used for anion-radical redox relay without any external oxidant. By avoiding using N-O/N-N homolysis or radical initiators to generate iminyl radicals, this strategy realizes modular synthesis of N-H indoles and analogs from abundant feedstocks, such as toluene and nitrile derivatives, and also enables rapid synthesis of large scale pharmaceuticals.

Identifiers

PMID30796224
PMCPMC6385223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.